Abstract
Retinal gene therapy has advanced significantly, offering potential treatments for inherited retinal diseases (IRDs) such as retinitis pigmentosa, which previously lacked effective interventions. Central to this progress are adeno-associated virus (AAV)-based delivery systems, which have become the primary platform for ocular gene therapy due to their favorable safety profile, ability to target specific retinal cell types, and long-lasting therapeutic effects. However, accumulating evidence reveals that even "immune-privileged" retinal microenvironments are not exempt from immune challenges, affecting both the safety and efficacy of these therapies. Both innate immune pathways and adaptive responses can induce intraocular inflammation, leading to reduced transgene expression and compromised treatment. Understanding how these immune mechanisms interact with therapeutic outcomes is crucial for developing effective intervention strategies. This review examines evidence from both animal models and human trials to explore how immune activation affects treatment efficacy across various delivery methods and vector designs. We also assess emerging strategies aimed at protecting retinal function while reducing systemic toxicity.
| Original language | English |
|---|---|
| Article number | 1664968 |
| Number of pages | 16 |
| Journal | FRONTIERS IN IMMUNOLOGY |
| Volume | 16 |
| DOIs | |
| State | Published - 15 Oct 2025 |
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (NSFC No. 82471086), the Hubei Provincial Health and Health Technology Project (WJ2025Z003).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- retinal gene therapy
- immune responses
- inherited retinal diseases
- adeno-associated virus (AAV)
- immunomodulation
Indexed by
- SCIE
- Scopus
Fingerprint
Dive into the research topics of 'Immune responses in retinal gene therapy: challenges, mechanisms, and future strategies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver